Cargando…
Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey
OBJECTIVE: To test whether diabetic polyneuropathies (DPNs), retinopathy, or nephropathy is more prevalent in subjects with impaired glycemia (IG) (abnormality of impaired fasting glucose [IFG], impaired glucose tolerance [IGT], or impaired HbA(1c) [IA1C]) than in healthy subjects (non-IG). RESEARCH...
Autores principales: | Dyck, Peter J., Clark, Vicki M., Overland, Carol J., Davies, Jenny L., Pach, John M., Dyck, P. James B., Klein, Christopher J., Rizza, Robert A., Melton, L. Joseph, Carter, Rickey E., Klein, Ronald, Litchy, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322692/ https://www.ncbi.nlm.nih.gov/pubmed/22355020 http://dx.doi.org/10.2337/dc11-1421 |
Ejemplares similares
-
Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2017) -
Assessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies
por: Dyck, Peter J., et al.
Publicado: (2013) -
Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
por: Ziegler, Dan, et al.
Publicado: (2011) -
Solving the Riddle of the Sphinx May Provide New Insights Into Diabetes and Polyneuropathy
por: Klein, Christopher J.
Publicado: (2015) -
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin‐mediated amyloidosis
por: Dyck, P. James B., et al.
Publicado: (2020)